Signaturefd, LLC Ultragenyx Pharmaceutical Inc. Transaction History

Signaturefd, LLC

$5.21 Billion
Q4 2024

A detailed history of Signaturefd, LLC transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, Signaturefd, LLC holds 835 shares of RARE stock, worth $31,805. This represents 0.0% of its overall portfolio holdings.

Number of Shares

835

Previous 875 4.57%

Holding current value

$31,805

Previous $48,000 27.08%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 10, 2025	SELL	$42.07 - $57.72 $1,682 - $2,308	-40 Reduced 4.57%	835 $35,000
Q3 2024 Oct 21, 2024	BUY	$40.21 - $59.36 $4,503 - $6,648	112 Added 14.68%	875 $48,000
Q2 2024 Jul 29, 2024	BUY	$37.42 - $51.61 $898 - $1,238	24 Added 3.25%	763 $31,000
Q1 2024 May 03, 2024	BUY	$43.02 - $53.69 $2,667 - $3,328	62 Added 9.16%	739 $34,000
Q4 2023 Jan 31, 2024	SELL	$31.73 - $49.19 $7,615 - $11,805	-240 Reduced 26.17%	677 $32,000
Q3 2023 Nov 03, 2023	SELL	$34.92 - $46.66 $3,631 - $4,852	-104 Reduced 10.19%	917 $32,000
Q2 2023 Aug 01, 2023	BUY	$37.35 - $52.15 $11,391 - $15,905	305 Added 42.6%	1,021 $47,000
Q1 2023 Apr 28, 2023	SELL	$36.99 - $48.71 $27,594 - $36,337	-746 Reduced 51.03%	716 $28,000
Q4 2022 Jan 27, 2023	BUY	$33.72 - $46.33 $29,066 - $39,936	862 Added 143.67%	1,462 $67,000
Q3 2022 Nov 08, 2022	BUY	$39.96 - $66.14 $14,425 - $23,876	361 Added 151.05%	600 $25,000
Q2 2022 Aug 10, 2022	BUY	$45.8 - $85.4 $4,488 - $8,369	98 Added 69.5%	239 $14,000
Q1 2022 May 02, 2022	BUY	$62.2 - $84.4 $2,923 - $3,966	47 Added 50.0%	141 $10,000
Q4 2021 Jan 25, 2022	BUY	$73.71 - $87.86 $4,938 - $5,886	67 Added 248.15%	94 $8,000
Q3 2021 Oct 28, 2021	BUY	$77.92 - $102.4 $1,636 - $2,150	21 Added 350.0%	27 $2,000
Q2 2021 Jul 26, 2021	SELL	$92.19 - $115.71 $1,014 - $1,272	-11 Reduced 64.71%	6 $1,000
Q1 2021 Apr 30, 2021	SELL	$106.9 - $167.73 $534 - $838	-5 Reduced 22.73%	17 $2,000
Q4 2020 Feb 11, 2021	BUY	$84.4 - $177.39 $1,350 - $2,838	16 Added 266.67%	22 $3,000
Q3 2020 Nov 03, 2020	BUY	$72.98 - $90.0 $437 - $540	6 New	6 $0
Q4 2018 Feb 13, 2019	SELL	$38.89 - $77.3 $38 - $77	-1 Closed	0 $0
Q1 2018 May 08, 2018	BUY	$44.33 - $58.52 $44 - $58	1 New	1 $0

Others Institutions Holding RARE

# of Institutions

344

Shares Held

84.7M

Call Options Held

675K

Put Options Held

846K

View Full List

About Ultragenyx Pharmaceutical Inc.

Ticker RARE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,036,896
Market Cap $2.67B
Description
Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...

More about RARE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Signaturefd, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Signaturefd, LLC with notifications on news.

Account